Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 52,751,330
- Total 13F value
- $79,656,235
- Share change
- -2,836,608
- SEC-reported price per share
- $1.51
- Number of holders
- 96
- Value change
- -$3,936,309
- Number of buys
- 40
- Number of sells
- 53
- Shares outstanding
- 94,920,069
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
96
Top holders
10
ZNTL full security history
Ownership snapshot
Full 13F holder table
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
William Thurman Walters
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: William Thurman Walters
Showing 1-6 of 15 holder rows.
Quick read
William Thurman Walters leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens William Thurman Walters's linked filing trail.
Comparable ownership
Top 5
William Thurman Walters
9.9%
VANGUARD GROUP INC
4.6%
MILLENNIUM MANAGEMENT LLC
1.3%
FMR LLC
0.2%
Matrix Capital Management Company...
15%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| William Thurman Walters |
13D/G
Walters William T
|
9.9%
|
$10,081,500
7,050,000 shares
|
+$786,500 | 29 Jan 2025 |
| VANGUARD GROUP INC |
13D/G
13F
The Vanguard Group · Company
|
4.6%
|
$4,677,873
3,271,240 shares
|
$0 | 31 Dec 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
Company
|
1.3%
from 13D/G
|
$4,033,097
3,476,808 shares
|
— | 30 Jun 2025 |
| FMR LLC |
13D/G
13F
Company
|
0.2%
|
$251,484
175,863 shares
|
$0 | 29 Nov 2024 |
| Matrix Capital Management Company, LP |
13F
Company
|
15%
|
$16,193,569
13,959,973 shares
|
— | 30 Jun 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
2.9%
|
$3,241,000
2,799,020 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
96
Shares
52,751,330
Rows available
96
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
115
Q3 2025 holders
96
Holder diff
-19
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|